BJ
BOLGER JOHN C
Director
BoardM
Insider track record
Board DirectorAcross 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by BOLGER JOHN C, Director. Director active across 1 company, notably Fulgent Genetics, Inc.. Cumulatively, 12 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €15k. Activity tracked since 20 May 2021. The latest transaction was filed on 1 August 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
1,600 shares0Common StockSEC:0001209191-22-044287:0
313 shares@ US$3.9250.0003% mcap5.0% of flowCommon StockSEC:0001209191-22-033477:0
2,000 shares0Common StockSEC:0001209191-22-030954:0
625 shares@ US$3.9250.0005% mcap9.6% of flowCommon StockSEC:0001209191-22-015590:0
312 shares@ US$3.9250.0002% mcap4.6% of flowCommon StockSEC:0001209191-21-054292:0
312 shares@ US$3.9254.6% of flowCommon StockSEC:0001209191-21-054292
125 shares@ US$74.170.0017% mcap33.7% of flowCommon StockSEC:0001209191-21-038717:0
125 shares@ US$74.1733.7% of flowCommon StockSEC:0001209191-21-038717
313 shares@ US$3.930.0002% mcap4.4% of flowCommon StockSEC:0001209191-21-037821:0
313 shares@ US$3.934.4% of flowCommon StockSEC:0001209191-21-037821
2,000 shares0Common StockSEC:0001209191-21-035449:0
2,000 shares0Common StockSEC:0001209191-21-035449
About BOLGER JOHN C
John C. Bolger is a Board Member at Fulgent Genetics, Inc. He plays a key role in the governance of the company, bringing his expertise in biotechnology and management. His involvement is essential in guiding strategic decisions.